Shares of Emcure Pharmaceuticals Ltd ended at ₹1,857.80, down by ₹73.95, or 4.15%, on the BSE.Read More

Emcure Pharmaceuticals gets CDSCO nod for MASH treatment in adults with liver fibrosis
- by stefan

Shares of Emcure Pharmaceuticals Ltd ended at ₹1,857.80, down by ₹73.95, or 4.15%, on the BSE.Read More